United States· US:36000-244_19ade85b-3da4-44af-8ad0-d68d15a48193

Tobramycin

A medicinal product containing tobramycin sulfate, registered in United States by Baxter Healthcare Corporation.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTobramycinATC—REGISTER NO.US:36000-244_19ade85b…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TOBRAMYCIN SULFATE
Manufacturer
Baxter Healthcare Corporation
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    3600024425
    25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE
  • ndc11
    36000-244-25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tobramycin sulfate in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tobramycin sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Bramitob, Tobi
  • Belgium · Obracin, Tobi
  • Bulgaria · Tобрекс, Тобрамизил
  • Cyprus · Bramitob, Ikobel
  • Czechia · Bramitob, Tobramycin Vioser
  • Germany · Bramitob, Gernebcin
  • Denmark · Nebcina, Tobi
  • Estonia · Tobramycin Via Pharma, Tobrex
  • Spain · Bramitob, Tobrabact
  • Finland · Tobi
  • France · Nebcine, Tobi
  • United Kingdom (Northern Ireland) · Bramitob, Munuza
  • Greece · Bramitob, Eyetobrin
  • Croatia · Bramitob, Tobrex
  • Hungary · Bramitob, Brulamycin
  • Ireland · Bramitob, Tobi
  • Iceland · Tobi Podhaler, Vantobra
  • Italy · Bramicil, Bramitob
  • Liechtenstein · Tobi Podhaler, Vantobra
  • Lithuania · Bramitob, Tobramycin Via Pharma
  • Luxembourg · Obracin, Tobi
  • Latvia · Bramitob, Tobramycin Via Pharma
  • Malta · Tobi, Tobrex
  • Netherlands · Bramitob, Obracin
  • Norway · Bramitob, Nebcina
  • Poland · Bramitob, Tobramycin Via Pharma
  • Portugal · Bramitob, Tobi
  • Romania · Tobi, Tobramicină Sun
  • Sweden · Bramitob, Nebcina
  • Slovenia · Tobrex
  • Slovakia · Bramitob, Tobrex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ec5f7663-2b71-46b0-b8c1-81b82528e8bb
GET /v1/drugs/ec5f7663-2b71-46b0-b8c1-81b82528e8bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "source": "ndc",
  "strength": "40",
  "substance": "TOBRAMYCIN SULFATE",
  "productndc": "36000-244",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA206965",
  "marketing_category": "ANDA"
}

See everything about tobramycin sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.